First fair-price pharmacy to open its doors in Gurugram today

GURUGRAM: Medicines and diagnostic tests will be available in the city at a lower prices than current ones.

The MCG, along with the health department and a pharma company, will on Saturday launch Haryana’s first such fair-price pharmacy — Affordable Medicines and Reliable Implants for Treatment (Amrit) — in Gurugram, where medicines, particularly for cancer and cardiovascular diseases, will be available at prices three times less than the market rate.

Union health minister JP Nadda will inaugurate the Amrit pharmacy at Mahaveer Chowk near the Gurugram bus stand and the diagnostic laboratory in Sector 39, officials said on Friday. This is part of the Union government’s plan to open 300 such pharmacies across the country.

“All medicines at the pharmacy will be sold at subsidised rates, upto 60% of the MRP,” said an MCG official. “Anyone with a prescription will be able to make purchase at the pharmacy. And though it will stock drugs for all diseases, it would especially focus on easy availability of medicines for cancer and cardiovascular diseases,” he added.

Though the diagnostic laboratory will be inaugurated on Saturday, it will be operational from April. “All kinds of diagnostic test facilities will be available at the centre. The rates for the lab will be the same as applicable under the Central Government Health Scheme,” said the official.

The first Amrit pharmacy was opened at AIIMS in Delhi in 2015. The project was launched by the Centre in association with state-owned HLL Lifecare limited. However, in many places, these pharmacies were reported to be inefficient in handling the demands. And given Gurugram’s size, many say, it might prove to be the same case here as well.

  • Related Posts

    WHO launches new primary health care course to strengthen health systems globally

    Health is a human right – yet not everyone can access the health services they need, when and where they need them, without financial hardship. Primary health care (PHC) provides…

    Ayurveda needs stronger evidence, safety monitoring for market adoption, says CCRAS

    Bengaluru: The Central Council for Research in Ayurvedic Sciences (CCRAS) has called for stronger scientific evidence, safety monitoring and translation of research into market-ready technologies to improve the credibility and…

    Leave a Reply

    Your email address will not be published. Required fields are marked *

    You Missed

    WHO launches new primary health care course to strengthen health systems globally

    WHO launches new primary health care course to strengthen health systems globally

    Ayurveda needs stronger evidence, safety monitoring for market adoption, says CCRAS

    Ayurveda needs stronger evidence, safety monitoring for market adoption, says CCRAS

    Yashoda Medicity Successfully Performs High-Risk Kidney Transplant in 28-Year- Old Woman

    Yashoda Medicity Successfully Performs High-Risk Kidney Transplant in 28-Year- Old Woman

    Avacta delivers two clinical stage peptide-drug conjugates to target delivery of toxic payloads into the tumour microenvironment

    Avacta delivers two clinical stage peptide-drug conjugates to target delivery of toxic payloads into the tumour microenvironment

    US FDA approves first gene therapy for paediatric patients with Sanfilippo syndrome type A

    US FDA approves first gene therapy for paediatric patients with Sanfilippo syndrome type A

    Technology and accessibility are key to growth of advanced treatment of heart diseases, says expert

    Technology and accessibility are key to growth of advanced treatment of heart diseases, says expert